INCOG BioPharma Advances Digital Excellence in Manufacturing with Veeva Vault Quality Suite

Fast-growing CDMO unifies quality content, processes, and training for seamless collaboration with clients and partners

PLEASANTON, Calif., Sept. 7, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that INCOG BioPharma Services implemented Veeva Vault Quality Suite as a foundation for digital excellence across its new 90,000-square-foot manufacturing facility. Vault Quality empowers INCOG BioPharma's teams with a connected digital system that simplifies working with partners and provides transparency to customers.

"Launching our facility with modern quality solutions that can keep up with strict project requirements while streamlining collaboration was a top priority," said JR Humbert, vice president of quality, INCOG BioPharma. "Veeva Vault Quality Suite helps us deliver real-time visibility to clients, increasing operational efficiency, GxP compliance, and trust."

A contract development and manufacturing organization (CDMO) specializing in sterile injectable fill-finish, INCOG BioPharma is unifying quality functions on a single platform to speed manufacturing and delivery and maintain high levels of quality and compliance. The company uses Veeva Vault QMS to accelerate quality processes using built-in best practices, Veeva Vault QualityDocs to streamline document management and automate workflows, and Veeva Vault Training to develop curricula that ensure job qualifications. Together, these applications provide INCOG with a single source of content, quality events, and training for greater insights and efficiency while delivering documentation transparency to customers.

"Using Veeva Vault Quality, INCOG can increase efficiency and intelligence for proactive quality management," said Ashley Wentworth, senior director, Veeva Vault Quality. "We're thrilled to partner with INCOG BioPharma to advance their mission of creating better and faster paths to market for life-saving drugs."

The Vault Quality Suite includes Vault QMS, Vault QualityDocs, Veeva Vault Validation Management, Veeva Vault Station Manager, Vault Training, Veeva LearnGxP, and Veeva Vault LIMS to automate and harmonize quality processes globally.

Learn how companies are transforming quality management across the value chain at Veeva R&D and Quality Summit. Life sciences industry professionals can register for the Oct. 19-20 in-person event in Boston.

For more on Veeva Vault Quality Suite, visit: veeva.com/QualityManufacturing 
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems 
Follow @veevasystems on Twitter: twitter.com/veevasystems

Designed to deliver better. Discover the INCOG way.

INCOG BioPharma has been designed and built from decades of experience with a clear purpose: to deliver better CDMO services in the injectable drug product space. The company's service offering includes filling drug product into vials, syringes, and cartridges. INCOG BioPharma also offers support services to include formulation development, analytical development, stability testing and storage, and final inspection, labeling, packaging, and device assembly. With our dedicated team, best-in-class processes, and state-of-the-art equipment, we deliver meaningful results and stand-out customer experiences. We stand behind our motto, "in it with you," from the moment we start work on your project. We go above and beyond to understand your requirements, meet your needs, and foster a truly collaborative partnership.

For more information, visit www.incogbiopharma.com and follow us at INCOG BioPharma Services on LinkedIn.

Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2022, which you can find here (a summary of risks which may impact our business can be found on pages 39 and 40), and in our subsequent SEC filings, which you can access at sec.gov.

Contact:

Deivis Mercado
Veeva Systems
925-226-8821
[email protected]

SOURCE Veeva Systems